Acetic Acid

SCHEMBL5166423

CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2A ADRA2B ADRA2C ADRB2 AGTR1 AVPR1A AVPR1B AVPR2 BDKRB2 CALCR CHRNA3 CHRNB4 ESR1 ESR2 GHSR GNRHR GSC1 HSPA8 MALT1 MC1R MC4R NOS1 NOS2 NOS3 OPRK1 OXTR RAMP1 RAMP2 RAMP3 SCN5A SSTR1 SSTR2 SSTR3 SSTR4 SSTR5 dacA dacB dacC folP ftsI mrcA mrcB mrdA rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	GNRHR known ✓	P30968	2/20	0.72

▸	ABCC2	Q92887	1/20	0.74

▸	PTGS1	P23219	1/20	0.66

▸	C5AR1	P21730	2/20	0.59

▸	APLNR	P35414	4/20	0.56

▸	KISS1R	Q969F8	1/20	0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Leuprolide SCHEMBL1357405	1.00	ABCC2 (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR
Acetic Acid SCHEMBL28807132	1.00	ABCC2 (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR
Deslorelin SCHEMBL205614	1.00	ABCC2 (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR
Leuprolide SCHEMBL29359846	1.00	ABCC2 (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR
Leuprolide SCHEMBL1654929	1.00	ABCC2 (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR
Leuprolide SCHEMBL22288711	1.00	ABCC2 (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR
Leuprolide SCHEMBL27849465	0.99	ABCC2 (0.73)	ABCC2GNRHRPTGS1C5AR1APLNR
Leuprolide SCHEMBL25418953	0.99	GNRHR (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR
Deslorelin SCHEMBL59413	0.99	GNRHR (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR
Leuprolide SCHEMBL172917	0.99	GNRHR (0.74)	ABCC2GNRHRPTGS1C5AR1APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-1007080-B1	Formulation for the sustained release of peptide agonists and analogues of GnRH	PEPTECH LTD (AU)	2007-04-18	—	—	EP	disclosed
EP-1007080-A4	SUSTAINED PEPTIDE-RELEASE FORMULATION	PEPTECH LTD (AU)	2006-01-18	—	—	EP	disclosed
EP-1104296-A4	BIOIMPLANT FORMULATION	PEPTECH LTD (AU)	2004-11-10	—	—	EP	disclosed
EP-1104296-A1	BIOIMPLANT FORMULATION	PEPTECH LIMITED (AU)	2001-06-06	—	—	EP	disclosed
EP-1007080-A1	SUSTAINED PEPTIDE-RELEASE FORMULATION	Peptech Limited (AU)	2000-06-14	—	—	EP	disclosed
WO-2000004897-A1	BIOIMPLANT FORMULATION	PEPTECH LIMITED (AU)	2000-02-03	—	—	WO	disclosed
WO-1998008533-A1	SUSTAINED PEPTIDE-RELEASE FORMULATION	PEPTECH LIMITED (AU)	1998-03-05	—	—	WO	disclosed